AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIOCRYST PHARMACEUTICALS INC Director's Dealing 2014

May 12, 2014

31868_dirs_2014-05-12_7047132b-9736-4e1f-ad23-6104f34aac72.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2014-05-09

Reporting Person: Stonehouse Jon P (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-09	Common Stock	M	3801	$3.26	Acquired	634043	Direct
2014-05-09	Common Stock	F	1610	$7.70	Disposed	632433	Direct
2014-05-09	Common Stock	M	26991	$6.68	Acquired	659424	Direct
2014-05-09	Common Stock	F	23416	$7.70	Disposed	636008	Direct
2014-05-09	Common Stock	M	9625	$4.15	Acquired	645633	Direct
2014-05-09	Common Stock	F	5188	$7.70	Disposed	640445	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-09	Emp. Stock Option (Right to Buy)	$3.26	M	3801	Disposed	2018-03-14	Common Stock (3801)	Direct
2014-05-09	Emp. Stock Option (Right to Buy)	$6.68	M	26991	Disposed	2020-03-01	Common Stock (26991)	Direct
2014-05-09	Stock Option (Right to Buy)	$4.15	M	9625	Disposed	2021-03-01	Common Stock (9625)	Direct